Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Expectations of multiple sclerosis patients and their families: a qualitative study in iran.
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Prognostic Factors of MS Conversion in Optic Neuritis.
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Perceptions of caregiver distress, health behaviors, and provider health-promoting communication and their relationship to stress management in MS caregivers.
Intractable vomiting and hiccups as the presenting symptom of neuromyelitis optica.
Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort.
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort.
IL-17-induced MiR-873 attributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin editing enzyme.
Variations of the UNC13D Gene in Patients with Autoimmune Lymphoproliferative Syndrome.
Monoclonal Antibodies in Treatment of Multiple Sclerosis.
The incidence and prevalence of multiple sclerosis in nova scotia, Canada.
Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system.
Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact.
Pharmacological inhibition of caspase-2 protects axotomised retinal ganglion cells from apoptosis in adult rats.
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage.
The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.
Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore.
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.
The Norwegian Multiple Sclerosis Registry and Biobank.
Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'
Pathogenesis of Pediatric Multiple Sclerosis.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
Pages
« first
‹ previous
…
363
364
365
366
367
368
369
370
371
…
next ›
last »